Phreesia [PHR] vs Ge Healthcare [GEHC] Detailed Stock Comparison
Phreesia
NYSE
Loading...
Ge Healthcare
NASDAQ
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Phreesia wins in 6 metrics, Ge Healthcare wins in 11 metrics, with 0 ties. Ge Healthcare appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Phreesia | Ge Healthcare | Better |
|---|---|---|---|
| P/E Ratio (TTM) | N/A | 14.75 | N/A |
| Price-to-Book Ratio | 5.34 | 3.38 | Ge Healthcare |
| Debt-to-Equity Ratio | 2.60 | 107.67 | Phreesia |
| PEG Ratio | -40.10 | 15.42 | Phreesia |
| EV/EBITDA | -27.85 | 10.91 | Phreesia |
| Profit Margin (TTM) | -13.94% | 11.22% | Ge Healthcare |
| Operating Margin (TTM) | -46.68% | 14.62% | Ge Healthcare |
| EBITDA Margin (TTM) | N/A | 14.62% | N/A |
| Return on Equity | -22.67% | 25.80% | Ge Healthcare |
| Return on Assets (TTM) | -8.75% | 5.77% | Ge Healthcare |
| Free Cash Flow (TTM) | $8.29M | $1.55B | Ge Healthcare |
| Dividend Yield | N/A | 0.24% | N/A |
| 1-Year Return | 16.83% | -13.67% | Phreesia |
| Price-to-Sales Ratio (TTM) | 3.41 | 1.65 | Ge Healthcare |
| Enterprise Value | $986.85M | $40.09B | Ge Healthcare |
| EV/Revenue Ratio | 2.35 | 2.01 | Ge Healthcare |
| Gross Profit Margin (TTM) | 69.40% | 39.65% | Phreesia |
| Revenue per Share (TTM) | $7 | $44 | Ge Healthcare |
| Earnings per Share (Diluted) | $-1.02 | $4.88 | Ge Healthcare |
| Beta (Stock Volatility) | 0.74 | 1.28 | Phreesia |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Phreesia vs Ge Healthcare Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Phreesia | 0.63% | 2.54% | -4.93% | 6.42% | -6.80% | 7.23% |
| Ge Healthcare | 1.27% | 3.08% | -4.26% | 2.13% | -17.71% | -8.14% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Phreesia | 16.83% | 4.53% | -9.48% | 12.54% | 12.54% | 12.54% |
| Ge Healthcare | -13.67% | 26.89% | 26.89% | 26.89% | 26.89% | 26.89% |
Performance & Financial Health Analysis: Phreesia vs Ge Healthcare
| Metric | PHR | GEHC |
|---|---|---|
| Market Information | ||
| Market Cap | $1.43B | $32.87B |
| Market Cap Category | Small cap | Large cap |
| 10 Day Avg. Volume | 403,230 | 5,234,860 |
| 90 Day Avg. Volume | 422,913 | 4,035,617 |
| Last Close | $27.01 | $72.00 |
| 52 Week Range | $17.07 - $30.53 | $57.65 - $94.80 |
| % from 52W High | -11.53% | -24.05% |
| All-Time High | $81.59 (Feb 08, 2021) | $94.80 (Feb 10, 2025) |
| % from All-Time High | -66.90% | -24.05% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.46% | 0.04% |
| Quarterly Earnings Growth | 0.15% | 0.14% |
| Financial Health | ||
| Profit Margin (TTM) | -0.14% | 0.11% |
| Operating Margin (TTM) | -0.47% | 0.15% |
| Return on Equity (TTM) | -0.23% | 0.26% |
| Debt to Equity (MRQ) | 2.60 | 107.67 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $4.51 | $21.27 |
| Cash per Share (MRQ) | $7.48 | $8.19 |
| Operating Cash Flow (TTM) | $32.38M | $2.00B |
| Levered Free Cash Flow (TTM) | $28.64M | $1.58B |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 0.24% |
| Last 12-Month Dividend | $0.00 | $0.18 |
Valuation & Enterprise Metrics Analysis: Phreesia vs Ge Healthcare
| Metric | PHR | GEHC |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | N/A | 14.75 |
| Forward P/E | -40.10 | 15.42 |
| PEG Ratio | -40.10 | 15.42 |
| Price to Sales (TTM) | 3.41 | 1.65 |
| Price to Book (MRQ) | 5.34 | 3.38 |
| Market Capitalization | ||
| Market Capitalization | $1.43B | $32.87B |
| Enterprise Value | $986.85M | $40.09B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 2.35 | 2.01 |
| Enterprise to EBITDA | -27.85 | 10.91 |
| Risk & Other Metrics | ||
| Beta | 0.74 | 1.28 |
| Book Value per Share (MRQ) | $4.51 | $21.27 |
Financial Statements Comparison: Phreesia vs Ge Healthcare
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | PHR | GEHC |
|---|---|---|
| Revenue/Sales | $109.68M | $4.78B |
| Cost of Goods Sold | $33.57M | $2.77B |
| Gross Profit | $76.12M | $2.01B |
| Research & Development | $29.63M | $344.00M |
| Operating Income (EBIT) | $-7.61M | $628.00M |
| EBITDA | $2.03M | $842.00M |
| Pre-Tax Income | $-5.38M | $692.00M |
| Income Tax | $1.01M | $104.00M |
| Net Income (Profit) | $-6.39M | $588.00M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | PHR | GEHC |
|---|---|---|
| Cash & Equivalents | $84.22M | $2.45B |
| Total Current Assets | $203.29M | $9.74B |
| Total Current Liabilities | $114.02M | $9.97B |
| Long-Term Debt | $8.80M | $7.06B |
| Total Shareholders Equity | $264.81M | $9.42B |
| Retained Earnings | $-801.50M | $3.81B |
| Property, Plant & Equipment | $17.24M | $369.00M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | PHR | GEHC |
|---|---|---|
| Operating Cash Flow | $15.59M | $509.00M |
| Capital Expenditures | $-2.79M | $-152.00M |
| Free Cash Flow | $9.20M | $98.00M |
| Debt Repayment | $-2.64M | $-257.00M |
| Common Stock Repurchase | $0 | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | PHR | GEHC |
|---|---|---|
| Shares Short | 2.34M | 6.62M |
| Short Ratio | 4.77 | 1.72 |
| Short % of Float | 0.05% | 0.02% |
| Average Daily Volume (10 Day) | 403,230 | 5,234,860 |
| Average Daily Volume (90 Day) | 422,913 | 4,035,617 |
| Shares Outstanding | 58.73M | 456.96M |
| Float Shares | 56.03M | 455.36M |
| % Held by Insiders | 0.04% | 0.00% |
| % Held by Institutions | 0.97% | 0.81% |
Dividend Analysis & Yield Comparison: Phreesia vs Ge Healthcare
| Metric | PHR | GEHC |
|---|---|---|
| Last 12-Month Dividend | $0.00 | $0.18 |
| Last 12-Month Dividend Yield | N/A | 0.24% |
| 3-Year Avg Annual Dividend | $0.00 | $0.11 |
| 3-Year Avg Dividend Yield | N/A | 0.04% |
| 3-Year Total Dividends | $0.00 | $0.33 |
| Ex-Dividend Date | N/A | Jul 25, 2025 |